Meeting
2011 ASCO Annual Meeting
Detection of HER2 status of circulating tumor cells and disseminated tumor cells using a microfluidic platform (cell enrichment and extraction technology [CEE]).
Authors
S. Krishnamurthy
University of Texas M. D. Anderson Cancer Center, Houston, TX
S. Krishnamurthy , F. Z. Bischoff , J. A. Mayer , K. Wong , S. Mikolajczyk , T. Pham , H. M. Kuerer , A. Lodhi , A. Bhattacharyya , C. Hall , A. Lucci Jr.
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - HER2/ER
Track
Breast Cancer
Sub Track
HER2+
Citation
J Clin Oncol 29: 2011 (suppl; abstr 613)
Abstract #
613
Poster Bd #
10G
Abstract Disclosures
Similar Posters
Poster
2012 ASCO Annual Meeting
Detection of discordant HER2 status by FISH in circulating tumor cells and disseminated tumor cells in early-stage breast cancer using a microfluidic-based cell enrichment and extraction platform (OncoCEE).
First Author: Savitri Krishnamurthy
Poster
2011 ASCO Annual Meeting
Redefining CTCs: Detection of additional circulating tumor cells using an antibody capture cocktail and HER2 FISH.
First Author: F. Z. Bischoff
First Author: Natália Polidorio
Poster
2020 ASCO Virtual Scientific Program
Adding precision to 2018 ASCO/CAP HER2 testing guidelines in breast cancer with genomic profiling.
First Author: Adam Brufsky